BE2014C034I2 - Derivatives of 3-(2-oxo- 1,3']bipyrrolidinyl-3-ylidenemethyl)-cephems - Google Patents

Derivatives of 3-(2-oxo- 1,3']bipyrrolidinyl-3-ylidenemethyl)-cephems

Info

Publication number
BE2014C034I2
BE2014C034I2 BE2014C034C BE2014C034C BE2014C034I2 BE 2014C034 I2 BE2014C034 I2 BE 2014C034I2 BE 2014C034 C BE2014C034 C BE 2014C034C BE 2014C034 C BE2014C034 C BE 2014C034C BE 2014C034 I2 BE2014C034 I2 BE 2014C034I2
Authority
BE
Belgium
Prior art keywords
hydrogen
compounds
ocor
coor
salts
Prior art date
Application number
BE2014C034C
Other languages
English (en)
Original Assignee
Basilea Pharmaceutica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basilea Pharmaceutica Ag filed Critical Basilea Pharmaceutica Ag
Publication of BE2014C034I2 publication Critical patent/BE2014C034I2/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/48Methylene radicals, substituted by hetero rings
    • C07D501/56Methylene radicals, substituted by hetero rings with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BE2014C034C 1998-06-15 2014-05-15 Derivatives of 3-(2-oxo- 1,3']bipyrrolidinyl-3-ylidenemethyl)-cephems BE2014C034I2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP98110888 1998-06-15
EP98117099 1998-09-10
EP99927894A EP1087980B1 (fr) 1998-06-15 1999-06-07 Derives de 3-(2-oxo- 1,3']bipyrrolidinyl-3-ylidenemethyl)-cephemes
PCT/EP1999/003907 WO1999065920A1 (fr) 1998-06-15 1999-06-07 Derives de 3-(2-oxo-[1,3']bipyrrolidinyl-3-ylidenemethyl)-cephemes

Publications (1)

Publication Number Publication Date
BE2014C034I2 true BE2014C034I2 (en) 2018-08-24

Family

ID=26149347

Family Applications (1)

Application Number Title Priority Date Filing Date
BE2014C034C BE2014C034I2 (en) 1998-06-15 2014-05-15 Derivatives of 3-(2-oxo- 1,3']bipyrrolidinyl-3-ylidenemethyl)-cephems

Country Status (28)

Country Link
EP (1) EP1087980B1 (fr)
JP (1) JP3872955B2 (fr)
KR (1) KR100411915B1 (fr)
CN (1) CN1136222C (fr)
AR (1) AR018675A1 (fr)
AT (1) ATE231871T1 (fr)
AU (1) AU754732B2 (fr)
BE (1) BE2014C034I2 (fr)
BR (2) BRPI9911178B8 (fr)
CA (1) CA2334568C (fr)
CO (1) CO5080758A1 (fr)
DE (1) DE69905162T2 (fr)
DK (1) DK1087980T3 (fr)
ES (1) ES2190222T3 (fr)
FR (1) FR14C0044I2 (fr)
GT (1) GT199900084A (fr)
HU (1) HUP0105426A3 (fr)
ID (1) ID27686A (fr)
IL (1) IL139872A0 (fr)
LU (1) LU92564I2 (fr)
MA (1) MA26650A1 (fr)
NO (1) NO20006350D0 (fr)
PA (1) PA8475701A1 (fr)
PE (1) PE20000645A1 (fr)
PL (1) PL344994A1 (fr)
SV (1) SV1999000075A (fr)
TN (1) TNSN99114A1 (fr)
WO (1) WO1999065920A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6267100A (en) * 1999-07-07 2001-01-30 F. Hoffmann-La Roche Ag Vinylpyrrolidinone derivatives with substituted thiazole ring
DE60123513T2 (de) 2000-04-19 2007-05-10 Basilea Pharmaceutica Ag Verfahren zur Herstellung von D-Asparaginderivaten
US6504025B2 (en) * 2000-05-24 2003-01-07 Basilea Pharmaceutica Ag Process for the preparation of vinyl-pyrrolidinone cephalosporin derivatives
JP5230934B2 (ja) * 2003-03-27 2013-07-10 バジリア ファルマスーチカ アーゲー 結晶形態のセファロスポリン
EP1656930A1 (fr) * 2004-11-10 2006-05-17 Basilea Pharmaceutica AG Formulation lyophilisée stabilisée pour des dérivés des céphalosporines
AR071318A1 (es) 2008-04-15 2010-06-09 Basilea Pharmaceutica Ag Benzhidril ester del acido (6r,7r)-7-{2-(5-amino-[1,2,4]tiadiazol-3-il)-2-[(z)-tritiloxiimino]-acetilamino}-3-[(r)-1'-terc-butoxicarbonil-2-oxo-[1,3']bipirrolidinil-(3e)-ilidenometil]-8-oxo-5-tia-1-aza-biciclo[4.2.0]oct-2-eno-2-carboxilico cristalino; su elaboracion y uso
WO2010072672A1 (fr) 2008-12-24 2010-07-01 Basilea Pharmaceutica Ag Nouveaux polymorphes cristallins du ceftobiprole
ES2565952T3 (es) * 2009-05-25 2016-04-07 Sandoz Ag Método para la producción de ceftobiprol medocaril
BR112012028678A2 (pt) 2010-05-10 2015-09-15 Basilea Pharmaceutica Internat Ltd processo de oxidação para preparar derivados de 3-formil-cefem

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69737382T2 (de) * 1996-11-06 2007-10-31 Basilea Pharmaceutica Ag Vinylpyrrolidinon-Cephalosporin-Derivate
TW415949B (en) * 1996-12-19 2000-12-21 Hoffmann La Roche Vinyl pyrrolidine cephalosporin derivatives with basic substituents

Also Published As

Publication number Publication date
AU4508199A (en) 2000-01-05
ES2190222T3 (es) 2003-07-16
CO5080758A1 (es) 2001-09-25
AU754732B2 (en) 2002-11-21
KR100411915B1 (ko) 2003-12-18
LU92564I2 (fr) 2014-12-01
DK1087980T3 (da) 2003-05-26
MA26650A1 (fr) 2004-12-20
JP2002518401A (ja) 2002-06-25
EP1087980A1 (fr) 2001-04-04
DE69905162T2 (de) 2003-12-24
HUP0105426A3 (en) 2002-12-28
AR018675A1 (es) 2001-11-28
BRPI9911178C1 (pt) 2021-05-25
KR20010052866A (ko) 2001-06-25
HUP0105426A2 (hu) 2002-05-29
CA2334568A1 (fr) 1999-12-23
CA2334568C (fr) 2009-02-24
BR9911178B1 (pt) 2013-10-29
CN1305484A (zh) 2001-07-25
NO20006350L (no) 2000-12-13
BRPI9911178B8 (pt) 2017-03-07
ATE231871T1 (de) 2003-02-15
TNSN99114A1 (fr) 2005-11-10
IL139872A0 (en) 2002-02-10
JP3872955B2 (ja) 2007-01-24
SV1999000075A (es) 2000-05-02
GT199900084A (es) 2000-12-05
FR14C0044I2 (fr) 2015-02-20
DE69905162D1 (de) 2003-03-06
CN1136222C (zh) 2004-01-28
NO20006350D0 (no) 2000-12-13
PE20000645A1 (es) 2000-07-26
PL344994A1 (en) 2001-11-19
FR14C0044I1 (fr) 2014-07-18
PA8475701A1 (es) 2000-09-29
EP1087980B1 (fr) 2003-01-29
BR9911178A (pt) 2001-03-13
ID27686A (id) 2001-04-19
WO1999065920A1 (fr) 1999-12-23

Similar Documents

Publication Publication Date Title
AU3461697A (en) Heterocyclic compounds, their production and use
PT848004E (pt) Derivados pirrolidina tendo actividade inibidora da fosfolipase a2
ES539446A0 (es) Un procedimiento para preparar un derivado de dihidropiridazinona
DK0956033T3 (da) Totalsyntese af amino-Hip-analogen af didemnin A
CA2334568A1 (fr) Derives de 3-(2-oxo-[1,3']bipyrrolidinyl-3-ylidenemethyl)-cephemes
AU6220300A (en) Benzofurylpiperazine serotonin agonists
EP1026162A4 (fr) Agent anti-rhumatismal
WO2000051589A3 (fr) Composes inhibiteurs d'atpase-(h+) de type vacuolaire, compositions et uitlisations associees
PL344696A1 (en) Hyperforin derivatives, the use thereof and formulations containing them
CA2261271A1 (fr) Derives de dihydrodibenzo(b,e)oxazepine, et compositions medicamenteuses les comportant
CA2049655A1 (fr) Composition pharmaceutique pour inhiber l'aggregation des plaquettes
AU7094796A (en) Sesquiterpene derivatives having antiviral activity
KR970042503A (ko) 약제학적 화합물
EP0201349A3 (fr) Dérivés de tétrazole
KR960014780B1 (en) Dental plaque inhibitor composition and its preparation
EP0049999A3 (fr) Composés cycliques, leur préparation et leur utilisation
MX9601953A (es) Nuevo compesto derivados de 5h-tiazolo [3,2-a] pirimidin-5-ona.
AU6675696A (en) A novel asymmetric synthesis of r and s warfarin and its analogs
WO2002040005A3 (fr) Blocage de canaux sodiques par derives phenoles
HK62292A (en) Prophylactic and curing composition for arteriosclerosis
IE873474L (en) Dibenzo£be|oxepinacetic acid derivatives, their preparation¹and pharmaceutical compositions containing them
HUT68015A (en) New compound leustroducsin h, its preparation and pharmaceutical compositions containing them
CA2016300A1 (fr) Analogue de la prostaglandine i
JPS54126732A (en) Antidepressant containing 2-(3-aminopropoxy)diphenyl ether or its derivative